- In May 2024, US Medical Innovations, LLC announced that its Canady Helios Cold Plasma (CHCP) Ablation System obtained FDA 510(k) clearance for soft tissue ablation during surgery. This approval marks a significant advancement in the application of cold plasma technology in surgical procedures, offering a non-thermal method for tissue ablation, which may reduce damage to surrounding tissues and enhance patient recovery times
- In April 2024, Singapore-based Mirari Doctor PTE LTD introduced the MIRARI Cold Plasma System, a portable device designed for skin rejuvenation and wound healing. Approved by the Thai FDA and Vietnam's Ministry of Health, this system offers a user-friendly solution for healthcare professionals, with potential applications in dermatology, wound care, and cancer therapies
- In October 2023, Aurora Cold Plasma Sterilisation, a leading French MedTech company, announced its recognition as a Laureate of the EIC Accelerator 2023, receiving support through blended finance. This accolade highlights Aurora's innovative advancements in sterilization technology, specifically designed for reusable medical devices previously deemed non-sterilizable
- In September 2023, researchers at IIT Jodhpur developed the Novel Cold-Plasma Detergent in Environment (CODE) device, designed to improve indoor air quality by neutralizing over 99.99% of harmful pathogens. This innovation addresses significant air pollution concerns, particularly in indoor environments
- In June 2023, Adtec Healthcare Limited, a pioneer in cold plasma medical technology for treating chronic and infected wounds, became an independent entity, separating from Adtec Europe Ltd. This strategic spin-out aims to broaden cold plasma's clinical application globally, starting with expansion efforts in Europe and entry into the US market, seeking FDA approval through new clinical studies and partnerships
